FACTANKER

iTeos Therapeutics, Inc.: cashflow_financing

Value{"amount": 806000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2023-01-01 – 2023-09-30
Statuscurrent
EntityiTeos Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-23-059757
Retrieved: 2026-08-19T18:13:05.345676+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/7c9ac0c0-aa7d-4235-a372-08d38f2becbf

History